RENO, Nev., May 27, 2004 (BUSINESS WIRE) -- Jim Holmes, CEO Lifeline Biotechnologies Inc. (OTC: LBTT), announced the company has entered into a contract to supply its proprietary Mastascope(TM) to its recently acquired Middle Eastern distributor, New Horizon Investment and Development. The Mastascope(TM) is designed for physicians to utilize in cases of women's nipple discharge and provides for the examination of the interior of the breast ducts to determine the source of the discharge. The device could save many needless surgeries. The ducts of the breast is where the vast majority of breast cancers originate.

Carlo Micheletti, Lifeline's director of international marketing and sales, just returned from Egypt where the distributorship agreement and an initial order were finalized. Micheletti noted, "New Horizon Investment and Development, located in Cairo, Egypt, is a well-established medical device company. New Horizon has been in business over 12 years and employs 15 people. The company has several organizational alliances operating throughout the Middle Eastern region. In addition to Egypt, the contract granted to New Horizon includes the countries of Saudi Arabia, Kuwait, Yemen, Oman, Bahrain, Qatar, Jordan, Syria, Lebanon, Algeria, Libya, Tunisia, and Morocco. The distribution contract requires the minimum sales of $1,100,000 over the next four years. Other companies represented by New Horizon include Siemen's Ultrasound Systems, iCad Mammo Readers, Select Surgical for OB/GYN products, to name a few." Micheletti went on to say, "This distributorship is the result of the Mastascope(TM) being introduced last March at the European Breast Surgeon's conference in Hamburg, Germany. There are numerous other prospects that were obtained at the conference and we are following up on those as quickly as possible."

Lifeline's Web site address: lbti.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. In particular, when used in the preceding discussion, the words "believe," "expects," "projects," "forecasts," "intends," "will," "anticipated," "could," or "may," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the act and subject to the safe harbor created by the act. Except for historical information, all of the statements, expectations and assumptions contained in the foregoing are forward-looking statements that involve a number of risks and uncertainties.

SOURCE: Lifeline Biotechnologies Inc.

Lifeline Biotechnologies Inc.
Jim Holmes, 775-324-1933
jholmes777@aol.com or jholmes@lbti.com
or
Stock Enterprises
Investor Relations, 866-242-2405 (toll free)
stockenter@aol.com

Customize your Business Wire news & multimedia to match your needs.
Get breaking news from companies and organizations worldwide.
Logon for FREE today at www.BusinessWire.com.

Copyright (C) 2004 Business Wire. All rights reserved.